TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Altro Health raised $7 million in seed funding led by NFX to develop and market software for gyms, trainers and medspas offering lab testing and clinician-prescribed treatments. The company says more than 500 businesses already use its platform; details on revenue, patient outcomes and how the new funding will affect clinical oversight were not provided.
Altro Health, a software company that helps gyms, personal trainers and medspas offer lab testing and clinician-prescribed treatments under their own brands, has raised $7 million in seed funding. NFX led the round, which the company plans to use for product development, hiring, sales and marketing as it expands a service category that brings medical offerings into wellness businesses.
Altro’s platform supports offerings including peptides, GLP-1 medications and hormone therapy, as well as lab testing. The company says its board-certified clinical team supervises each service and that products are supplied by licensed 503A and 503B pharmacies. The gyms and other businesses retain their own branding and client relationships, while Altro provides the software and clinical infrastructure. The source report does not detail the prescribing process or the specific responsibilities shared by Altro, clinicians and participating businesses.
Altro says businesses can begin offering services in as few as two days, and that more than 500 businesses are already on the platform. Its Starter plan is listed at $319 per month, billed quarterly, and includes a co-branded storefront, patient portal, product catalog, lab testing and the ability to set prices. A $599-per-month Pro plan adds a storefront on the business’s own domain, marketing tools, premium lab panels with mobile blood draws and priority support. Multi-location operators can receive custom pricing.
The funding round included Founder Collective and Abby Miller Levy of Primetime Partners, according to the report. Altro founder and CEO Andrea Corleto said the company chose to serve wellness businesses rather than compete directly for consumers. NFX general partner James Currier said the firm saw a new consumer category without a clear leader and emphasized the need for infrastructure that can meet demand safely at scale. Those statements reflect the company’s and investor’s views, not independent evidence of clinical safety or market demand.
A New Route Into Wellness Clinics
The round backs a model that could make medical services more accessible through businesses people already visit for fitness or wellness. Rather than opening a clinic under its own name, a gym or trainer can use Altro’s branded storefront and clinical support to add testing and prescription offerings. That could give smaller operators a route into services that may otherwise require specialized staffing and systems, while giving Altro a way to reach customers through partner businesses.
The arrangement also puts questions of clinical responsibility and consumer trust at the center of the business. Prescription treatments require medical judgment, while gyms and trainers generally operate in a different role. Altro says clinicians supervise its services, but the report does not explain how eligibility, follow-up care, adverse effects or referrals are managed. The distinction matters to consumers deciding whether a wellness venue is also an appropriate place to seek medical treatment.
As an affiliate, we earn on qualifying purchases.
Gyms Add Medical Offerings
Altro is entering a market where some fitness businesses are already adding clinical services. The source report says Massachusetts gym owner Andrew Boimila offers peptides through provider Asher Med. In February, UFC Gym announced a joint venture with NexGen MD Scientific to open clinics offering GLP-1s, hormone replacement therapy and peptides, starting at two California locations and with a planned expansion across its network over two years. Life Time has offered similar services through its Miora clinics since late 2023, while Dallas-based Recess Fitness introduced RecessRx.
The report also cites a New Consumer survey released this year in which one-third of younger consumers said they would consider peptides on the recommendation of a healthcare or wellness professional. That finding describes stated interest, not actual use or clinical outcomes. It helps explain why companies are pursuing partnerships that connect wellness businesses with medical providers, but it does not establish the size or long-term prospects of the market.
“Direct-to-consumer brands are fighting over the same customers, so we went after something bigger.”
— Andrea Corleto, Altro Health founder and CEO
As an affiliate, we earn on qualifying purchases.
Clinical Oversight Details Remain Limited
The funding announcement and Altro’s reported service model are clear, but important operating details are not. The source report does not specify which clinicians evaluate patients, how prescriptions are issued, what follow-up patients receive, or how responsibility is divided when a participating business markets a treatment. It also does not provide information on adverse events, patient outcomes, revenue, funding terms beyond the round size, or independent verification of the reported 500-business count.
It is also unclear how many of the platform’s partners currently offer each service, how many customers have used them, or whether the reported two-day onboarding applies across all locations and products. No information was provided on when Altro expects its new hires or product changes to be complete.
As an affiliate, we earn on qualifying purchases.
Funding Targets Product and Growth
Altro says it will direct the seed funding toward product development, hiring, sales and marketing. The company has not announced specific milestones, a hiring timetable or plans for new clinical services. Its next measurable developments are likely to include updates on platform features and partner growth, though no dates were given in the source report.
For customers and wellness operators, further detail on clinician oversight, treatment eligibility and follow-up would help clarify how the service works in practice. The company’s expansion will also take place alongside other gym-clinic partnerships, including UFC Gym’s announced rollout. The scale of adoption and the quality of clinical safeguards remain to be established.
As an affiliate, we earn on qualifying purchases.
Key Questions
What does Altro Health do?
Altro provides software and clinical support for gyms, trainers and medspas seeking to offer lab testing and clinician-prescribed products under their own brands.
How much funding did Altro raise?
Altro raised $7 million in seed funding, led by NFX, with participation from Founder Collective and Abby Miller Levy of Primetime Partners, according to the source report.
Which services can participating businesses offer?
The platform supports lab testing, peptides, GLP-1 medications and hormone therapy. The report says services are supervised by Altro’s board-certified clinical team, but does not explain the full prescribing and follow-up process.
How many businesses use Altro?
Altro says more than 500 businesses are on its platform. The source report does not provide an independent verification or a breakdown of how many actively offer each service.
What will Altro do with the new funding?
The company says it plans to spend the money on product development, hiring, sales and marketing. It has not given specific milestones or a timetable.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
